ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Apogee Therapeutics Inc

Apogee Therapeutics Inc (APGE)

39.94
1.61
(4.20%)
Closed 17 March 7:00AM
39.94
-0.08
(-0.20%)
After Hours: 8:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
39.94
Bid
28.25
Offer
45.10
Volume
665,998
38.34 Day's Range 41.00
29.10 52 Week Range 71.75
Market Cap
Previous Close
38.33
Open
38.63
Last Trade Time
Financial Volume
US$ 26,650,701
VWAP
40.0162
Average Volume (3m)
583,111
Shares Outstanding
58,513,198
Dividend Yield
-
PE Ratio
-27.88
Earnings Per Share (EPS)
-1.44
Revenue
-
Net Profit
-83.99M

About Apogee Therapeutics Inc

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Apogee Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker APGE. The last closing price for Apogee Therapeutics was US$38.33. Over the last year, Apogee Therapeutics shares have traded in a share price range of US$ 29.10 to US$ 71.75.

Apogee Therapeutics currently has 58,513,198 shares in issue. The market capitalisation of Apogee Therapeutics is US$2.24 billion. Apogee Therapeutics has a price to earnings ratio (PE ratio) of -27.88.

APGE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.3712.285633961235.5741.8735.13100459238.04001248CS
43.469.4846491228136.4841.8729.176392634.75011441CS
12-6.54-14.070567986246.4850.5629.158311138.1745391CS
26-11.99-23.088773348751.9363.529.152183545.02951672CS
52-29.77-42.705494190269.7171.7529.149774748.00578939CS
15618.4485.767441860521.572.2914.1946130542.51103462CS
26018.4485.767441860521.572.2914.1946130542.51103462CS

APGE - Frequently Asked Questions (FAQ)

What is the current Apogee Therapeutics share price?
The current share price of Apogee Therapeutics is US$ 39.94
How many Apogee Therapeutics shares are in issue?
Apogee Therapeutics has 58,513,198 shares in issue
What is the market cap of Apogee Therapeutics?
The market capitalisation of Apogee Therapeutics is USD 2.24B
What is the 1 year trading range for Apogee Therapeutics share price?
Apogee Therapeutics has traded in the range of US$ 29.10 to US$ 71.75 during the past year
What is the PE ratio of Apogee Therapeutics?
The price to earnings ratio of Apogee Therapeutics is -27.88
What is the reporting currency for Apogee Therapeutics?
Apogee Therapeutics reports financial results in USD
What is the latest annual profit for Apogee Therapeutics?
The latest annual profit of Apogee Therapeutics is USD -83.99M
What is the registered address of Apogee Therapeutics?
The registered address for Apogee Therapeutics is 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Apogee Therapeutics website address?
The website address for Apogee Therapeutics is www.apogeetherapeutics.com
Which industry sector does Apogee Therapeutics operate in?
Apogee Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M